Geminally di-substituted NSAID derivatives as Aβ42 lowering agents
View Patent ↗The present invention encompasses compounds of Formula I (I) or pharmaceutically acceptable salts thereof, wherein A is the base molecule of a propionic acid or acetic acid NSAID, or a derivative thereof, X is —CO 2 H, 1H-tetrazol-5-yl or 2H-tetrazol-5-yl and R 1 and R 2 are each independently selected from the group consisting of: C 1-6 alkyl and C 3-6 cycloalkyl, as well as pharmaceutical composition comprising said compounds and methods of using said compounds. The compounds of the present invention lower the level of Aβ 42 and are therefore useful for preventing, delaying or reversing the progression of Alzheimer's Disease.
1. A method for treating Alzheimer's Disease in a patient in need thereof comprising administering to said patient a compound of Formula I
or a pharmaceutically acceptable salt thereof, wherein:
X is —CO 2 H, 1H-tetrazol-5-yl or 2H-tetrazol-5-yl;
each R a may be substituted at any substitutable position on A and each R a is independently selected from the group consisting of: fluoro, chloro, bromo, NH 2 , methyl, ethyl, methoxy and CF 3 ;
R 1 and R 2 are each independently selected from the group consisting of: C 1-6 alkyl and C 3-6 cycloalkyl; and
A is selected from the group consisting of:
wherein for 38) above R a is substituted on A as shown and Z is selected from the group consisting of: phenyl, benzimidazolyl, benzofuranyl, benzopyrazolyl, benzotriazolyl, benzothiophenyl, benzoxazolyl, carbazolyl, carbolinyl, cinnolinyl, furanyl, imidazolyl, indolinyl, indolyl, indolazinyl, indazolyl, isobenzofuranyl, isoindolyl, isoquinolyl, isothiazolyl, isoxazolyl, naphthyridinyl, oxadiazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridopyridinyl, pyridazinyl, pyridyl, pyrimidyl, pyrrolyl, quinazolinyl, quinolyl, quinoxalinyl, thiadiazolyl, thiazolyl, thienyl, triazolyl, azetidinyl, 1,4-dioxanyl, hexahydroazepinyl, piperazinyl, piperidinyl, pyrrolidinyl, morpholinyl, thiomorpholinyl, dihydrobenzimidazolyl, dihydrobenzofuranyl, dihydrobenzothiophenyl, dihydrobenzoxazolyl, dihydrofuranyl, dihydroimidazolyl, dihydroindolyl, dihydroisooxazolyl, dihydroisothiazolyl, dihydrooxadiazolyl, dihydrooxazolyl, dihydropyrazinyl, dihydropyrazolyl, dihydropyridinyl, dihydropyrimidinyl, dihydropyrrolyl, dihydroquinolinyl, dihydrotetrazolyl, dihydrothiadiazolyl, dihydrothiazolyl, dihydrothienyl, dihydrotriazolyl, dihydroazetidinyl, methylenedioxybenzoyl, tetrahydrofuranyl, and tetrahydrothienyl,
in amount that is effective for treating Alzheimer's Disease.
2. A method for treating Alzheimer's Disease in a patient in need thereof comprising administering to said patient a compound of Formula I′
or a pharmaceutically acceptable salt thereof, wherein:
Z is selected from the group consisting of: phenyl, benzimidazolyl, benzofuranyl, benzopyrazolyl, benzotriazolyl, benzothiophenyl, benzoxazolyl, carbazolyl, carbolinyl, cinnolinyl, furanyl, imidazolyl, indolinyl, indolyl, indolazinyl, indazolyl, isobenzofiuranyl, isoindolyl, isoquinolyl, isothiazolyl, isoxazolyl, naphthyridinyl, oxadiazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridopyridinyl, pyridazinyl, pyridyl, pyrimidyl, pyrrolyl, quinazolinyl, quinolyl, quinoxalinyl, thiadiazolyl, thiazolyl, thienyl, triazolyl, azetidinyl, 1,4-dioxanyl, hexahydroazepinyl, piperazinyl, piperidinyl, pyrrolidinyl, morpholinyl, thiomorpholinyl, dihydrobenzimidazolyl, dihydrobenzofuranyl, dihydrobenzothiophenyl, dihydrobenzoxazolyl, dihydrofuranyl, dihydroimidazolyl, dihydroindolyl, dihydroisooxazolyl, dihydroisothiazolyl, dihydrooxadiazolyl, dihydrooxazolyl, dihydropyrazinyl, dihydropyrazolyl, dihydropyridinyl, dihydropyrimidinyl, dihydropyrrolyl, dihydroquinolinyl, dihydrotetrazolyl, dihydrothiadiazolyl, dihydrothiazolyl, dihydrothienyl, dihydrotriazolyl, dihydroazetidinyl, methylenedioxybenzoyl, tetrahydrofuranyl, and tetrahydrothienyl,
X is —CO 2 H, 1H-tetrazol-5-yl or 2H-tetrazol-5-yl,
R 1 and R 2 are each independently ethyl or methyl, and
each R a is independently selected from the group consisting of: fluoro, chloro, bromo, NH 2 , methyl, ethyl, methoxy and CF 3 ,
in amount that is effective for treating Alzheimer's Disease.
3. The method for treating Alzheimer's Disease in a patient in need thereof in accordance with claim 1 comprising administering to said patient a compound of Formula I wherein R 1 and R 2 are each C 1-4 alkyl and all other variables are as previously defined in amount that is effective for treating Alzheimer's Disease.
4. The method for treating Alzheimer's Disease in a patient in need thereof in accordance with claim 3 comprising administering to said patient a compound of Formula I wherein R 1 and R 2 are each methyl and all other variables are as previously defined in amount that is effective for treating Alzheimer's Disease.
5. The method for treating Alzheimer's Disease in a patient in need thereof in accordance with claim 1 comprising administering to said patient a compound of Formula I wherein X is —CO 2 H and all other variables are as previously defined in amount that is effective for treating Alzheimer's Disease.
6. A method for treating Alzheimer's Disease in a patient in need thereof in accordance with claim 1 comprising administering to said patient a compound of Formula I selected from the following group:
or a pharmaceutically acceptable salt of any of the above, in amount that is effective for treating Alzheimer's Disease.
7. The method for treating Alzheimer's Disease in a patient in need thereof in accordance with claim 2 comprising administering to said patient a compound of Formula I′a
or a pharmaceutically acceptable salt thereof, wherein:
X is —CO 2 H, 1H-tetrazol-5-yl or 2H-tetrazol-5-yl and
R 1 and R 2 are each independently ethyl or methyl, in amount that is effective for treating Alzheimer's Disease.